We are proud to announce the close of our $5.5M seed funding round led by TLV Partners, a major step forward in our mission to transform biological R&D through generative AI.

At Converge Bio, we’re at the forefront of leveraging Large Language Models (LLMs) trained on biological and chemical data to optimize and generate better biological products and bring them faster to market.

Check out our TechCrunch article